Further evidence for a dissociation between different forms of mnemonic expressions in a mouse model of age-related cognitive decline: effects of tacrine and S 17092, a novel prolyl endopeptidase inhibitor.
It has been demonstrated previously on the radial maze that the emergence of an age-related mnemonic impairment is critically dependent on the form which the discrimination problems took. Hence, when the arms were presented one by one (i.e., successive go-no-go discrimination), both adult and aged mice learned to distinguish between positive (baited) and negative (unbaited) arms readily, as evidenced by their increased readiness to enter positive relative to negative arms (i.e., by a differential in arm-entry latencies). A selective impairment in the aged mice was seen when these arms were presented subsequently as pairs, such that the mice were confronted with an explicit choice (i.e., simultaneous 2-choice discrimination). When discriminative performance was measured by the differential run speed between positive and negative arms, aged mice were also impaired. This was particularly pronounced in the 2-choice discrimination condition. We examined the effects of tacrine (3mg/kg, subcutaneously) or S 17092 (10mg/kg, orally) in aged mice on the three behavioral indices of this 2-stage spatial discrimination paradigm. The results indicated that: (1) Tacrine, but not S 17092, enhanced the acquisition of go-no-go discrimination as reflected in arm-entry latencies; (2) both drugs improved choice accuracy in simultaneous discrimination, although the effect of tacrine was less striking and, in particular, far from statistical significance in the very first 2-choice responses; and (3) neither drugs significantly affected run-speed performance. We conclude further that the specific patterns of drug effects on the three indices of discriminative performance might suggest that each index is associated with a distinct form of mnemonic expression relying on separate neural systems.
Marighetto
A
A
CNRS - UMR-5106, Laboratoire Neurosciences Comportementales and Cognitives, 33405 Talence Cedex, France. a.marighetto@neurocog.u-bordeaux.fr
Touzani
K
K
Etchamendy
N
N
Torrea
C C
CC
De Nanteuil
G
G
Guez
D
D
Jaffard
R
R
Morain
P
P
D000375:Aging / Q000523:psychology*; D000818:Animals; D002755:Choice Behavior / Q000187:drug effects / Q000502:physiology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D003072:Cognition Disorders / Q000209:etiology*; D004192:Discrimination, Psychological / Q000187:drug effects; D007211:Indoles / Q000494:pharmacology*; D018782:Maze Learning / Q000502:physiology*; D008568:Memory; D051379:Mice; D008810:Mice, Inbred C57BL; D000085822:Prolyl Oligopeptidases; D011930:Reaction Time / Q000187:drug effects; D012697:Serine Endopeptidases / Q000378:metabolism*; D015842:Serine Proteinase Inhibitors / Q000494:pharmacology*; D013619:Tacrine / Q000494:pharmacology*; D013844:Thiazoles / Q000494:pharmacology*; D053778:Thiazolidines; D013997:Time Factors
D002800:Cholinesterase Inhibitors; D007211:Indoles; C118986:S 17092-1; D015842:Serine Proteinase Inhibitors; D013844:Thiazoles; D053778:Thiazolidines; D013619:Tacrine; D012697:Serine Endopeptidases; D000085822:Prolyl Oligopeptidases